Vicore Pharma Holding AB (publ) (STO:VICO)
9.84
-0.40 (-3.91%)
Nov 20, 2026, 5:29 PM CET
Vicore Pharma Holding AB Market Cap
Vicore Pharma Holding AB has a market cap or net worth of 2.77 billion as of November 20, 2026. It is the 18,061st most valuable company in the world and the 231st biggest in Sweden. Its market cap has decreased by 2.73% in one year.
Market Cap
2.77B
Enterprise Value
2.00B
Revenue
3.83M
Global Rank
Country Rank
#231 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since December 10, 2015, Vicore Pharma Holding AB's market cap has increased from 87.82M to 2.77B, an increase of 3,055.88%. That is a compound annual growth rate of 37.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 2.77B | -12.88% |
| Dec 30, 2025 | 3.18B | 60.49% |
| Dec 30, 2024 | 1.98B | 25.12% |
| Dec 29, 2023 | 1.58B | 8.13% |
| Dec 30, 2022 | 1.47B | 46.67% |
| Dec 30, 2021 | 998.90M | -47.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Egetis Therapeutics AB | 5.17B |
| Hansa Biopharma AB | 4.59B |
| Saniona AB | 1.55B |
| Genovis AB (publ.) | 1.53B |
| Flerie AB | 1.08B |
| Infant Bacterial Therapeutics AB | 934.92M |
| AlzeCure Pharma AB | 783.26M |
| SynAct Pharma AB | 727.98M |